Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.
Adam Hotchkiss, Tiam Feridooni, Mark Baguma-Nibasheka, Kathleen McNeil, Sarita Chinni, Kishore B S Pasumarthi
Index: Am. J. Physiol. Cell Physiol. 308(7) , C557-69, (2015)
Full Text: HTML
Abstract
The biological effects of atrial natriuretic peptide (ANP) are mediated by natriuretic peptide receptors (NPRs), which can either activate guanylyl cyclase (NPRA and NPRB) or inhibit adenylyl cyclase (NPRC) to modulate intracellular cGMP or cAMP, respectively. During cardiac development, ANP serves as an early maker of differentiating atrial and ventricular chamber myocardium. As development proceeds, expression of ANP persists in the atria but declines in the ventricles. Currently, it is not known whether ANP is secreted or the ANP-NPR signaling system plays any active role in the developing ventricles. Thus the primary aims of this study were to 1) examine biological activity of ANP signaling systems in embryonic ventricular myocardium, and 2) determine whether ANP signaling modulates proliferation/differentiation of undifferentiated cardiac progenitor cells (CPCs) and/or cardiomyocytes. Here, we provide evidence that ANP synthesized in embryonic day (E)11.5 ventricular myocytes is actively secreted and processed to its biologically active form. Notably, NPRA and NPRC were detected in E11.5 ventricles and exogenous ANP stimulated production of cGMP in ventricular cell cultures. Furthermore, we showed that exogenous ANP significantly decreased cell number and DNA synthesis of CPCs but not cardiomyocytes and this effect could be reversed by pretreatment with the NPRA receptor-specific inhibitor A71915. ANP treatment also led to a robust increase in nuclear p27 levels in CPCs compared with cardiomyocytes. Collectively, these data provide evidence that in the developing mammalian ventricles ANP plays a local paracrine role in regulating the balance between CPC proliferation and differentiation via NPRA/cGMP-mediated signaling pathways.Copyright © 2015 the American Physiological Society.
Related Compounds
Related Articles:
2015-01-03
[Vaccine 33(2) , 346-53, (2014)]
2014-01-01
[BMC Biotechnol. 14 , 962, (2015)]
Process development for scum to biodiesel conversion.
2015-06-01
[Bioresour. Technol. 185 , 185-93, (2015)]
2015-06-01
[Bioresour. Technol. 185 , 49-55, (2015)]
Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.
2014-12-01
[Growth Factors 32(6) , 236-46, (2014)]